Researcher
Daan Dierickx
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Hematology (Division)
Responsible
From1 Oct 2019 → Today - Laboratory of Experimental Hematology (Division)
Member
From1 Oct 2013 → Today
Projects
1 - 10 of 15
- Molecular characterization of hyperactive T cell receptor signaling in peripheral T cell lymphoma to uncover druggable targetsFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of genetic events driving development of peripheral T cell lymphomaFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- GAINING INSIGHT IN THE MUTATIONAL PROFILE OF PT-DLBCL AND ASSESSING ITS BIOLOGICAL EFFECTS AND TRANSFORMING POTENTIALFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of rare lymphomas to uncover new biomarkers and treatment targets.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Degradation of CDK1 and HDACs as a strategy to treat T-cell malignanciesFrom1 Oct 2023 → TodayFunding: BOF - projects
- Characterization of non-canonical EZH2 transcriptional complexes to identify new therapeutic targets in peripheral T cell lymphoma.From1 Sep 2023 → TodayFunding: Other federal public and semi-governmental institutions
- Molecular characterization of genetic events driving development of peripheral T cell lymphomaFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Molecular characterization of hyperactive T cell receptor signaling in peripheral T cell lymphoma to uncover druggable targetsFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Viral Oncology: molecular biology and pathogenesis of post-transplant lymphoproliferative disorder (PTLD)From13 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Extensive preclinical validation of combinations of targeted treatment for peripheral T cell lymphomaFrom10 Aug 2021 → 30 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 203
- ALLELE study: A multicenter, open label, phase III study of tabelecleucel for solid organ or allogeneic hematopoietic cell transplant subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV plus PTLD) after failure of rituximab or rituximab and chemotherapy(2020)
Authors: Daan Dierickx
Pages: S1426 - S1427 - Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.(2020)
Authors: Daan Dierickx
Pages: 2805 - 2812 - Immuniteit, het Epstein-Barr virus en de micro-omgeving in lymfomen: karakterisatie van lymfoïde weefsels en rationale voor nieuwe therapeutische opportuniteiten(2020)
Authors: Lukas Marcelis, Thomas Tousseyn, Daan Dierickx, Robert Snoeck
- In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy(2020)
Authors: Lukas Marcelis, Koen Debackere, Peter Vandenberghe, Gregor Verhoef, Francesca Bosisio, Xavier Sagaert, Daan Dierickx, Thomas Tousseyn
Pages: 1751 - 1766 - Fulminant macrophage activation syndrome in a patient with anti-synthetase syndrome(2020)
Authors: Jean-Baptiste Vulsteke, Daan Dierickx, Patrick Verschueren, Ellen De Langhe
Pages: 1775 - 1777 - Bortezomib for autoimmune hemolytic anemia after intestinal transplantation(2020)
Authors: Noël Knops, Marie-Paule Emonds, Elena Levtchenko, Djalila Mekahli, Jacques Pirenne, Chris Van Geet, Daan Dierickx
- FER and FES tyrosine kinase fusions in follicular T-cell lymphoma(2020)
Authors: Koen Debackere, Thomas Tousseyn, Lukas Marcelis, Daan Dierickx, Peter Vandenberghe, Lucienne Michaux, Jan Cools
Pages: 584 - 588 - Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study(2019)
Authors: Charlotte Maggen, Daan Dierickx, Annouschka Laenen, Kristel Van Calsteren, Peter Vandenberghe, Frédéric Amant
Pages: E551 - E561 - Management of post-transplant lymphoproliferative disorders(2019)
Authors: Daan Dierickx, Vibeke Vergote
Pages: 74 - 77 - Role of interim and end of treatment positron emission tomography for response assessment and prediction of relapse in posttransplant lymphoproliferative disorder(2019)
Authors: Karolien Goffin, Vibeke Vergote, Thomas Tousseyn, Gregor Verhoef, Annouschka Laenen, Peter Vandenberghe, Daan Dierickx
Pages: 1041 - 1047